Chemically modified liposomes carrying TRAIL target activated hepatic stellate cells and ameliorate hepatic fibrosis in vitro and in vivo - Li, Qinghua; Ding, Youcheng; Guo, Xinlai; Luo, Shenggen; Zhuang, Huiren; Zhou, JingE; Xu, Nan; Yan, Zhiqiang (Journal of cellular and molecular medicine, 2019)
Keywords: 3T3 Cells; Animals; Apoptosis; Apoptosis - drug effects; Cell Line; Cell Membrane - drug effects; Cell membranes; Cytoplasm; Drug Carriers - chemistry; Fibrosis; hepatic fibrosis; Hepatic Stellate Cells - drug effects; Hepatic Stellate Cells - metabolism; Hepatocytes; Humans; liposome; Liposomes; Liposomes - chemistry; Liver; Liver cirrhosis; Liver Cirrhosis - drug therapy; Liver Cirrhosis - metabolism; Mice; Nanoparticles; Nanoparticles - chemistry; Original; Rodents; Stellate cells; targeting therapy; TNF-Related Apoptosis-Inducing Ligand - metabolism; TRAIL; TRAIL protein; Nanoparticles; TRAIL; targeting therapy; hepatic fibrosis; liposome; liver cirrhosis